NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression.
アクセス数 : 833 件
ダウンロード数 : 403 件
今月のアクセス数 : 1 件
今月のダウンロード数 : 0 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00036285
ファイル情報(添付) |
k6284_3.pdf
1.26 MB
種類 :
全文
|
ファイル情報(添付) |
k6284_1.pdf
169 KB
種類 :
抄録・要旨
|
ファイル情報(添付) |
k6284_2.pdf
158 KB
種類 :
抄録・要旨
|
タイトル ( eng ) |
NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression.
|
タイトル ( jpn ) |
nardilysinをコードするNRD1は、MMP2およびMMP3を介して食道がんの浸潤を促進させる
|
作成者 |
浦岡 直礼
|
抄録 |
Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide. In the present study, to identify novel prognostic markers or therapeutic targets for ESCC, we reviewed a list of genes with upregulated expression in ESCC compared with normal esophagus, as identified by our serial analysis of gene expression (SAGE) analysis. We focused on the NRD1 gene, which encodes the nardilysin protein. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) in 34 ESCC tissue samples revealed that mRNA expression of NRD1 was upregulated in 56% of ESCC tissue samples. Immunohistochemical analysis of nardilysin in 109 ESCC tissue samples demonstrated that 43 (39%) ESCC cases were positive for nardilysin. Nardilysin-positive ESCC cases were more advanced in terms of T classification (P = 0.0007), N classification (P = 0.0164), and tumor stage (P < 0.0001) than nardilysin-negative ESCC cases. Furthermore, nardilysin expression was significantly associated with poorer prognosis (P = 0.0258). Univariate and multivariate analyses revealed that nardilysin expression is an independent prognostic classifier of patients with ESCC. The invasiveness of NRD1-knockdown TE1 and TE5 esophageal cancer cell lines was less than that of the negative control siRNA-transfected cell lines. Expression of MMP2 and MMP3 mRNA was significantly lower in NRD1-knockdown TE5 cells than in negative control siRNA-transfected cells. These results suggest that nardilysin is involved in tumor progression, and is an independent prognostic classifier in patients with ESCC.
|
著者キーワード |
Esophageal cancer
NRD1
nardilysin
prognosis
invasion
|
NDC分類 |
医学 [ 490 ]
|
言語 |
英語
|
資源タイプ | 博士論文 |
権利情報 |
Copyright(c) by Author
|
出版タイプ | Not Applicable (or Unknown)(適用外。または不明) |
アクセス権 | オープンアクセス |
日付 |
[作成日] 2014-11-21
|
収録物識別子 |
Naohiro Uraoka, Naohide Oue, Naoya Sakamoto, Kazuhiro Sentani, Htoo Zarni Oo, Yutaka Naito, Tsuyoshi Noguchi and Wataru Yasui; NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression; Cancer Science, Volume 105, Issue 1, pages 134-140, January 2014 (DOI: 10.1111/cas.12316)
~を参照している
[DOI] http://dx.doi.org/10.1111/cas.12316
~を参照している
|
学位授与番号 | 甲第6284号 |
学位名 | |
学位授与年月日 | 2014-02-27 |
学位授与機関 |
広島大学
|